When was PERSIST.AI founded?

PERSIST.AI was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Where is PERSIST.AI located?

PERSIST.AI is headquartered in Woodland, United States.

Who is the current CEO of PERSIST.AI?

Karthik Raman of PERSIST.AI. They have also founded 1 company.

How many employees does PERSIST.AI have?

As of Sep 30, 2026, the latest employee count at PERSIST.AI is 35.

Is PERSIST.AI a funded company?

PERSIST.AI is a funded company, having raised a total of $16.7M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2023.

How much is PERSIST.AI worth?

The latest valuation of PERSIST.AI is $***** as of Jan 01, 2023.

When was the latest funding round of PERSIST.AI?

PERSIST.AI's latest funding was a $***** Series A round on May 19, 2025, with participation from 13 investors. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $951M in funding in 2026 to date.

Where does PERSIST.AI rank among its competitors?

PERSIST.AI ranks 31st amongst 898 active competitors, of which 30 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was PERSIST.AI, which secured $12M in May, 2025.

Who are the top competitors of PERSIST.AI?

PERSIST.AI's top competitors include Akums, Nivagen Pharmaceuticals and Jubilant Life Sciences. Among them, PERSIST.AI secured the most recent funding round in May, 2025.

PERSIST.AI - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.persist-ai.com/
Email ID: *****@persist-ai.com
Phone Number: +1 **********

Key Metrics

Founded Year

2022

Location

Woodland, United States

Stage

Series A

Total Funding

$16.7M in 3 rounds

Latest Funding Round

Series A, May 19, 2025, $*****

Post Money Valuation

$***** as on Jan 01, 2023

Investors

Spero Ventures & 14 more

Ranked

31^st among 898 active competitors

Employee Count

35 as on Sep 30, 2026

Similar Companies

Akums & 1108 more

View PERSIST.AI's full profile

PERSIST.AI has raised a total funding of $16.7M over 3 rounds. Its first funding round was on 2023. Its latest funding round was a Series A round on May 19, 2025 for $*****. 13 investors participated in its latest round. PERSIST.AI has 15 institutional investors.

Here is the list of recent funding rounds of PERSIST.AI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 19, 2025	3353414	Series A	3884385	9316905	3505823	2827808
May 08, 2023	7775791	Seed	1654229	2630773	4589508	Fellows Fund & 3 more
2023	7624	Seed	8400	5458	4880	Y Combinator

Access funding benchmarks and valuations. Sign up today!

View details of PERSIST.AI's funding rounds and investors

The founders of PERSIST.AI are Karthik Raman and Christopher Shelner. Karthik Raman is the CEO of PERSIST.AI.

Here are the details of PERSIST.AI's key team members:

Karthik Raman: Co-Founder & CEO of PERSIST.AI.
Contact Info: 1 email address
Christopher Shelner: Co-Founder & COO of PERSIST.AI.
Contact Info: 1 email address

View details of PERSIST.AI's Founder profiles and Board Members

PERSIST.AI's employee count trend

PERSIST.AI has 35 employees as of Sep 26. Here is PERSIST.AI's employee count trend over the years:

Uncover PERSIST.AI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PERSIST.AI include Akums, Nivagen Pharmaceuticals and Jubilant Life Sciences. Here is the list of Top 10 competitors of PERSIST.AI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital	65/100
2nd	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 2 others	60/100
3rd	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
4th	Windlas 2001, Gurugram (India), Public	Provider of regulatory affair, quality control, and market strategy services to biopharma sector	$13M	Tano Capital, HDFC Bank & 6 others	59/100
5th	Asahi Kasei 1931, Chiyoda-ku (Japan), Public	CDMO focused on manufacturing of liquid, solid & injectable drug formulations	-	Europa	55/100
6th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	Ampersand Capital, CPP Investments	51/100
7th	Unither 1993, Paris (France), Acquired	Contract development and manufacturing organization for proprietary and generic drugs	-	Credit Mutuel Equity, Picardie Investissement ... & 11 others	54/100
8th	Labiana 1958, Corbera de Llobregat (Spain), Unfunded	Contract laboratory and contract manufacturing services for pharmaceutical and animal health industries	-	-	54/100
9th	Leukocare 2003, Germany, Series B	Developer of proprietary stabilizing and protecting solutions for biologics formulation	$17.5M	Petrichor, LifeCare Partners	54/100
10th	Chugai Pharmaceutical 1925, Tokyo (Japan), Acquired	Developer of innovative pharmaceutical products and services	-	Digital Pharma Lab	54/100
31st	PERSIST.AI 2022, Woodland (United States), Series A	CDMO focused on manufacturing formulations for biopharma sectors	$16.7M	Lilly, Good AI Capital & 13 others	48/100